Indianapolis — Oct. 8, 2013 — Dow AgroSciences LLC, a wholly-owned subsidiary of The Dow Chemical Company (NYSE: DOW), has won a second lawsuit involving its Enlist technology. In a 28-page decision issued yesterday, the federal court ruled that Dow AgroSciences has the right to sell Enlist E3™ soybean seed and that Bayer’s lawsuit seeking to prevent Dow AgroSciences from doing so must, therefore, be dismissed. In reaching its decision, the Court indicated that it was unable to find objective evidence supporting Bayer’s arguments.
The lawsuit, initially filed in January 2012 by Bayer CropScience AG, alleged that Dow AgroSciences’ intention to sell Enlist E3 soybean seed infringed several of its glyphosate tolerance patents. Yesterday’s decision comes just five weeks after the Court of Appeals for the Federal Circuit affirmed Dow’s summary judgment win over Bayer in the first case initiated by Bayer involving Dow’s Enlist 2,4-D tolerance technology.
Dow AgroSciences remains committed to advancing technology for its customers and ensuring that its innovative technology such as the Enlist™ Weed Control System and Enlist E3™ soybeans are available for farmers as they struggle with weed control issues. “We repeatedly have expressed confidence in our legal position in each of the cases filed by Bayer concerning our Enlist technology, and the results we have obtained in these cases certainly validates our conviction,” said Ken Isley, Dow AgroSciences' General Counsel.
About Dow AgroSciences Dow AgroSciences, based in Indianapolis, Indiana, USA, develops leading-edge crop protection and plant biotechnology solutions to meet the challenges of the growing world. Dow AgroSciences is a wholly owned subsidiary of The Dow Chemical Company and had annual global sales of $6.4 billion in 2012. Learn more at www.dowagro.com . Follow Dow AgroSciences on Facebook , Twitter , and YouTube  or subscribe to our News Release RSS Feed .